Todos Medical (OTCMKTS: TOMDF) was a value play before it started running recently based on sound fundamental analysis, and now investors are...
Developing a vaccine to treat COVID-19 is hands down the best way to play the long term coronavirus stocks. Ultimately a vaccine...
Back at the end of July, we published this piece on Novavax Inc (NASDAQ:NVAX). The company had just put out data from...
It has only been a week since we last looked at Novavax Inc (NASDAQ:NVAX) but recent events necessitate a follow-up early this...
Back in May this year we urged our readers to look beyond the share price with Novavax Inc (NASDAQ:NVAX) and weigh the...
Novavax, Inc. (NASDAQ:NVAX) on Nov. 10 announced that enrollment has begun in a Phase 1 clinical trial of its respiratory syncytial virus...
Novavax, Inc. (NASDAQ:NVAX) reported third-quarter net loss of $19.7 million or $0.08 per share, wider than last year’s loss of $15.3 million...
Facebook Inc (NASDAQ:FB) said requests by governments for user information have risen by about a quarter in the first half of 2014...
Novavax, Inc. (NASDAQ:NVAX) released that its Gale Smith, Vice President of Vaccine Development at Novavax, presented at the 8th Vaccine and ISV...
Integrated Device Technology, Inc. (NASDAQ:IDTI) presents RSV F protein nanoparticle vaccine clinical data at the 8th Vaccine & ISV Congress in Philadelphia....